Ekso Bionics Europe GmbH of Hamburg at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Ekso Bionics Europe GmbH

Friesenweg 4, House 13, 22763 Hamburg
Germany
Telephone +49 40 8004049-0
Fax +49 40 8004049-10
enquiries@eksobionics.com

Hall map

MEDICA 2019 hall map (Hall 4): stand F02

Fairground map

MEDICA 2019 fairground map: Hall 4

Contact

Event Manager EMEA Rehcan Dogru

Phone
+49 (0) 40 800 4049 -0

Our range of products

Product categories

  • 04  Physiotherapy / Orthopaedic Technology
  • 04.12  Rehabilitation equipment and devices

Rehabilitation equipment and devices

Our products

Product category: Rehabilitation equipment and devices

EKSO BIONICS UNVEILS EKSO NR

The Next Generation Exoskeleton for Neurorehabilitation

Ekso Bionics today unveiled EksoNR, the next generation EksoGT— the most clinically used robotic exoskeleton. Developed for neurorehabilitation, EksoNR is an intuitive exoskeleton device that empowers patients recovering from stroke or other conditions to learn to walk again with a more natural gait. The device now includes new features and software enhancements to help physical therapists and patients get even more out of each rehabilitation session.

EksoNR is equipped with EksoView, a new touchscreen controller that allows therapists to intuitively adapt assistance to challenge patients using real-time feedback and perform outcome measures during use. Held in the palm of a therapists’ hand, EksoView provides visualization of various exercises beyond gait training, such as balancing, squatting from sit-to-stand positioning, lifting one leg, or standing in place, to actively engage patients and enhance the use of these beneficial features.

The optimized SmartAssist software enables EksoNR to have a smoother and more natural gait path when transitioning between steps. SmartAssist also gives gait symmetry and posture feedback and allows therapists to track patient progress with the upgraded EksoPulse, a cloud-based analytics solution. EksoPulse now uses rehabilitation data to generate insightful metrics and graphs for therapists and administrators to monitor patient progress and outcomes.

“Ekso Bionics is committed to developing the latest exoskeleton advances for rehabilitation. We continue to innovate to ensure physical therapists have access to the latest tools to deliver better patient outcomes and superior care in neurorehabilitation,” said Jack Peurach, Chief Executive Officer and President of Ekso Bionics. “EksoNR is a full neurorehabilitation tool that is effective, intuitive, and differentiating. There is an increasing demand for adoption, as our technology sets rehabilitation centers apart.”
EksoNR is cleared by the U.S. Federal Drug Administration for stroke and spinal cord injury rehabilitation. The device is also CE-marked and available in Europe.

Ekso Bionics will begin taking orders for EksoNR immediately. Existing customers will have the option to upgrade.

More Less

About us

Company details

Ekso Bionics helps people back on their feet

Ekso Bionics is a global pioneer in the manufacture of robotic exoskeletons. The EksoNR is used in medical rehabilitation. With its help, people with spinal cord injuries, or people who have had a stroke or suffered a traumatic brain injury, can learn to stand and walk again. Every year, nearly 2,000 people in Germany become paraplegic and around 300,000 people suffer a stroke.
 
Ekso Bionics was founded in 2005 in collaboration with the Berkeley Robotics and Human Engineering Laboratory of the University of California, Berkeley. The company’s headquarters are located in Richmond, California, USA. Its first innovations were exoskeletons allowing people to lift loads of up to 90 kg. The company supplies the industry and healthcare sectors. In 2010, it presented its first exoskeleton for patients with paralysis of the lower extremities. Initially known as eLegs, it was developed into the EksoNR. Ekso Bionics aims to boost human strength, stamina and mobility, thus improving the lives of millions of people.
 
Ekso Bionics has almost 60 patents and its first exoskeleton,
eLegs, was crowned one of the top 50 best inventions of the 2010 by Time Magazine.
 
The European headquarters of Ekso Bionics were opened in 2015. Based in Hamburg, 13 members of staff manage the EMEA market. The company is constantly increasing the number of partners using the EksoNR in treatment.
 
Worldwide, Ekso Bionics works together with more than 270 rehabilitation clinics and hospitals. In a two-phase training programme, the clinic staff are trained as Ekso-certified therapists in order to provide comprehensive support to the patient during training. The company supports the institutions in carrying out scientific studies and uses the resulting data to optimise the
EksoNR.

More Less

Company information as a PDF file